EPZ-6438: Selective EZH2 Inhibitor

2026-08-23

EPZ-6438 is a selective EZH2 inhibitor that blocks SAM-dependent PRC2 methyltransferase activity and lowers H3K27me3. Its nanomolar biochemical potency, activity in SMARCB1-deficient malignant rhabdoid tumor models, and effects in HPV-associated cervical cancer systems support its use in epigenetic cancer research.

Eudragit-Coated LNPs for Oral RNA Delivery

2026-08-22

The reference study develops a pH-responsive Eudragit® S 100 coating for lipid nanoparticles designed to protect RNA during gastric transit and enable release under intestinal-like conditions. Its in vitro results show that coating, phosphate-buffer conditioning, and simulated gastrointestinal exposure can preserve nucleic acid integrity and transfection capacity, while also highlighting the need for in vivo validation.

Azithromycin and Roxithromycin as Senolytics

2026-08-21

Alosetron in 5-HT3 Receptor Signaling Research

2026-08-21

Use Alosetron as a reversible 5-HT3 receptor antagonist to test whether serotonergic input modifies intestinal epithelial polarity, stem-cell fate, and downstream YAP-EGF-mTOR responses. This workflow complements CDC42 genetics by separating receptor-level effects from polarity-driven phenotypes in organoids, monolayers, and ex vivo intestinal tissue.

Prochlorperazine-Induced NMS: A Case Analysis

2026-08-20

A 2024 case report documents neuroleptic malignant syndrome after standard-dose prochlorperazine in an older adult, despite relatively modest creatine phosphokinase abnormalities. The report highlights the value of medication history, serial neurological assessment, and prompt benzodiazepine-plus-amantadine treatment when classic laboratory findings are absent.

Eclipta/Hordeum Extracts Delay Precocious Puberty

2026-08-20

Kim et al. evaluated an Eclipta prostrata–Hordeum vulgare extract complex in rat models of precocious puberty triggered by Danazol or a high-fat diet. The intervention delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without changing body weight, supporting further investigation of HPG-axis modulation by standardized botanical combinations.

Nilotinib (AMN-107): Reliable Cell Assays

2026-08-19

This scenario-led guide shows how Nilotinib (AMN-107), SKU A8232, can support interpretable cell viability, proliferation, and kinase-signaling experiments. It connects target biology with stock preparation, exposure design, endpoint interpretation, and practical product-selection criteria.

Purifying HLA-G+ Extravillous Trophoblasts

2026-08-19

Tsuda and colleagues present a reproducible workflow for isolating viable, highly purified HLA-G+ extravillous trophoblasts (EVT) from human placental tissue and applying them to phenotyping and short-term immune co-culture. The protocol addresses major limitations of trophoblast lines, stem-cell models, and organoids by preserving primary human EVT immunobiology for studies of maternal–fetal tolerance and placental inflammation.

hCG, H3K27 Methylation, and CXCL10 in Decidua

2026-08-18

The reference study identifies a hormone–chromatin–chemokine pathway in which human chorionic gonadotropin suppresses CXCL10 in human decidual cells through EZH2-dependent H3K27me3 deposition at the CXCL10 promoter. Its combination of primary decidual cell models, chromatin analysis, and CD8-cell recruitment assays provides a useful framework for interpreting how epigenetic regulation shapes immune tolerance at the maternal–fetal interface.

2X Taq PCR Master Mix for Spatial Assays

2026-08-18

Discover how 2X Taq PCR Master Mix (with dye) can support spatially resolved assays inspired by ambrosia beetle disease ecology. This guide connects endpoint PCR chemistry, sampling architecture, TA cloning, and interpretation limits without confusing DNA detection with pathogen viability.

AL-8810: Prostaglandin F2α Antagonist Workflows

2026-08-17

AL-8810 enables controlled interrogation of FP receptor signaling across smooth muscle, ocular, vascular, and endometrial models. This practical guide connects concentration-response pharmacology with ERK1/2, MMP-2, vascular-permeability, and tissue-remodeling readouts.

E. coli Uracil-DNA Glycosylase (UDG) Guide

2026-08-16

E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, excises uracil from single- and double-stranded DNA to support PCR product contamination elimination and DNA repair enzyme workflows. It is intended for scientific DNA research, not RNA substrates, oligonucleotides shorter than six bases, or diagnostic and medical applications.

Elobixibat hydrate: IBAT Assay Workflows

2026-08-15

Build mechanism-led assays around Elobixibat hydrate, from ileal transport inhibition to bile acid-driven secretion and GLP-1 signaling. This workflow separates luminal gastrointestinal activity from systemic exposure and supports translational studies in constipation, colonoscopy preparation, and metabolic disease.

Cannabidiol in Orofacial Pain: Mechanisms and Evidence

2026-08-15

A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce both inflammatory nociception and pain-related affective dysfunction in mouse models. Its main contribution is the separation of peripheral CB2-linked anti-inflammatory actions from central CB1-associated modulation of trigeminal and emotional circuits, providing a mechanistic framework for future endocannabinoid pain research.

mRNA LNP Formulation, Characterization, and Evaluation

2026-08-14

Ma et al. present an integrated, stepwise workflow that connects microfluidic mRNA lipid nanoparticle formulation with physicochemical characterization, cellular assays, and in vivo delivery analysis. Its main practical value is not a single optimized LNP composition, but a reproducible framework that helps researchers connect particle quality with protein expression, uptake, endosomal escape, biodistribution, and tolerability.